37 Einträge | 1, 2 › » |
Seite 1 / 2
![]() |
Update Breast Cancer 2019 Part 3 - Current Developments in Early Breast Cancer: Review and Critical Assessment by an International Expert Panel. |
Kolberg HC, Schneeweiss A, Fehm TN, Wöckel A, Huober J, Pontones C, Titzmann A, Belleville E, Lux MP, Janni W, Hartkopf AD, Taran FA, Wallwiener M, Overkamp F, Tesch H, Ettl J, Lüftner D, Müller V, Schütz F, Fasching PA, Brucker SY |
Geburtshilfe und Frauenheilkunde. 2019 May 21. doi: 10.1055/a-0887-0861. pii: 8870861. pmc: PMC6529230 |
PMID: 31148847 |
Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†. |
Piccart M, Hortobagyi GN, Campone M, Pritchard KI, Lebrun F, Ito Y, Noguchi S, Perez A, Rugo HS, Deleu I, Burris HA, Provencher L, Neven P, Gnant M, Shtivelband M, Wu C, Fan J, Feng W, Taran T, Baselga J |
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2014 Sep 17. pii: mdu456. doi: 10.1093/annonc/mdu456 |
PMID: 25231953 |
Effect of everolimus on bone marker levels and progressive disease in bone in BOLERO-2. |
Gnant M, Baselga J, Rugo HS, Noguchi S, Burris HA, Piccart M, Hortobagyi GN, Eakle J, Mukai H, Iwata H, Geberth M, Hart LL, Hadji P, El-Hashimy M, Rao S, Taran T, Sahmoud T, Lebwohl D, Campone M, Pritchard KI |
Journal of the National Cancer Institute. 2013 Feb 19. pii: djt026. doi: 10.1093/jnci/djt026 |
PMID: 23425564 |
Somatostatin receptor scintigraphy in primary cutaneous T- and B-cell lymphomas. |
Valencak J, Trautinger F, Raderer M, Chott A, Der-Petrossian M, Ivancic-Brandenberger E, Knobler R, Kurtaran A, Hoffmann M |
Journal of the European Academy of Dermatology and Venereology : JEADV. 2009 Jun 8. pii: JDV3330. doi: 10.1111/j.1468-3083.2009.03330.x |
PMID: 19515078 |
Post-treatment imaging of liver tumours. |
Schima W, Ba-Ssalamah A, Kurtaran A, Schindl M, Gruenberger T |
Cancer imaging : the official publication of the International Cancer Imaging Society. 2007 Oct 1. doi: 10.1102/1470-7330.2007.9047. pmc: PMC2727978 |
PMID: 17921098 |
11C-acetate positron emission tomography imaging and image fusion with computed tomography and magnetic resonance imaging in patients with recurrent prostate cancer. |
Wachter S, Tomek S, Kurtaran A, Wachter-Gerstner N, Djavan B, Becherer A, Mitterhauser M, Dobrozemsky G, Li S, Pötter R, Dudczak R, Kletter K |
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Apr 24. pii: JCO.2005.03.5279. doi: 10.1200/JCO.2005.03.5279 |
PMID: 16636343 |
Value of combined XCT/SPECT technology for avoiding false positive planar (123)I-MIBG scintigraphy. |
Ozer S, Dobrozemsky G, Kienast O, Beheshti M, Becherer A, Niederle B, Kainberger F, Dudczak R, Kurtaran A |
Nuklearmedizin. Nuclear medicine. 2004 Oct 13. pii: 04050164. doi: 10.1267/NUKL04050164 |
PMID: 15480505 |
Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET. |
Becherer A, Szabó M, Karanikas G, Wunderbaldinger P, Angelberger P, Raderer M, Kurtaran A, Dudczak R, Kletter K |
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2004 Jul 5. |
PMID: 15235062 |
Randomized, double-blind, placebo-controlled, phase III study of bevacizumab with docetaxel or docetaxel with placebo as first-line therapy for patients with locally recurrent or metastatic breast cancer (mBC): AVADO. |
Miles D, Chan A, Romieu G, Dirix LY, Cortes J, Pivot X, Tomczak P, Taran T, Harbeck N, Steger GG |
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Jan 1. pii: 10.1200/jco.2008.26.15_suppl.lba1011 |
PMID: 27951290 |
Characterization of patients who received prior chemotherapy for advanced breast cancer (ABC) in BOLERO-2. |
Campone M, Lebrun F, Noguchi S, Pritchard KI, Burris HA, Beck JT, Ito Y, Bachelot T, Pistilli B, Melichar B, Petrakova K, Arena FP, Erdkamp F, Harb WA, Litton JK, Brechenmacher T, El-Hashimy M, Taran T, Gnant M |
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Jan 31. doi: 10.1200/jco.2013.31.26_suppl.151 |
PMID: 28136563 |
Patient-reported physical, emotional, and social functioning in advanced breast cancer: Insights from BOLERO-2. |
Hortobagyi GN, Lebrun F, Beck JT, Neven P, Baselga J, Petrakova K, Dakhil SR, Sabatini S, Komorowski A, Chouinard EE, Young RR, Gnant M, Pritchard KI, Zhang J, Ziemiecki R, Brechenmacher T, Taran T, Sahmoud T, Noguchi S |
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Jan 31. doi: 10.1200/jco.2013.31.26_suppl.155 |
PMID: 28136549 |
BOLERO-2: Efficacy and safety of first-line everolimus plus exemestane in advanced breast cancer. |
Campone M, Gnant M, Neven P, Pistilli B, Baselga J, Bauly H, Taran T, Sahmoud T, Hortobagyi GN |
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Jan 31. doi: 10.1200/jco.2013.31.26_suppl.152 |
PMID: 28136546 |
Effects of everolimus (EVE) on disease progression in bone and bone markers (BMs) in patients (pts) with bone metastases (mets). |
Baselga J, Rugo HS, Noguchi S, Pritchard KI, Burris HA, Piccart-Gebhart MJ, Eakle JF, Mukai H, Iwata H, El-Hashimy M, Rao S, Panneerselvam A, Taran T, Hortobagyi GN, Sahmoud T, Lebwohl DE, Gnant M |
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Feb 1. doi: 10.1200/jco.2012.30.27_suppl.102 |
PMID: 28146729 |
Safety of everolimus for women over age 65 with advanced breast cancer (BC): 12.5-month follow-up of BOLERO-2. |
Burris HA, Gnant M, Baselga J, Piccart-Gebhart MJ, Noguchi S, Dakhil SR, Srimuninnimit V, Puttawibul P, Csoszi T, Heng DY, Bourgeois H, Gonzalez-Martin A, Osborne K, Mukhopadhyay P, Taran T, Campone M, Hortobagyi GN, Sahmoud T, Pritchard KI |
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Feb 1. doi: 10.1200/jco.2012.30.27_suppl.104 |
PMID: 28146724 |
Everolimus for postmenopausal women with advanced breast cancer: Updated results of the BOLERO-2 phase III trial. |
Noguchi S, Pritchard KI, Burris HA, Rugo HS, Gnant M, Hortobagyi GN, Latini L, Yardley DA, Melichar B, Petrakova K, Harb W, Feng W, Cahana A, Taran T, Campone M, Baselga J, Sahmoud T, Lebwohl DE, Piccart-Gebhart MJ |
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Feb 1. doi: 10.1200/jco.2012.30.27_suppl.99 |
PMID: 28146687 |
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia. |
Maude SL, Laetsch TW, Buechner J, Rives S, Boyer M, Bittencourt H, Bader P, Verneris MR, Stefanski HE, Myers GD, Qayed M, De Moerloose B, Hiramatsu H, Schlis K, Davis KL, Martin PL, Nemecek ER, Yanik GA, Peters C, Baruchel A, Boissel N, Mechinaud F, Balduzzi A, Krueger J, June CH, Levine BL, Wood P, Taran T, Leung M, Mueller KT, Zhang Y, Sen K, Lebwohl D, Pulsipher MA, Grupp SA |
The New England journal of medicine. doi: 10.1056/NEJMoa1709866 |
PMID: 29385370 |
Hospital Malnutrition, a Call for Political Action: A Public Health and NutritionDay Perspective. |
Hiesmayr M, Tarantino S, Moick S, Laviano A, Sulz I, Mouhieddine M, Schuh C, Volkert D, Simon J, Schindler K |
Journal of clinical medicine. 2019 Nov 22. pii: jcm8122048. doi: 10.3390/jcm8122048 |
PMID: 31766583 |
Activated PI3Kδ breaches multiple B cell tolerance checkpoints and causes autoantibody production. |
Lau A, Avery DT, Jackson K, Lenthall H, Volpi S, Brigden H, Russell AJ, Bier J, Reed JH, Smart JM, Cole T, Choo S, Gray PE, Berglund LJ, Hsu P, Wong M, O'Sullivan M, Boztug K, Meyts I, Uzel G, Notarangelo LD, Brink R, Goodnow CC, Tangye SG, Deenick EK |
The Journal of experimental medicine. pii: 132760. doi: 10.1084/jem.20191336 |
PMID: 31841125 |
Repeat Transcatheter Aortic Valve Replacement for Transcatheter Prosthesis Dysfunction. |
Landes U, Webb JG, De Backer O, Sondergaard L, Abdel-Wahab M, Crusius L, Kim WK, Hamm C, Buzzatti N, Montorfano M, Ludwig S, Schofer N, Voigtlaender L, Guerrero M, El Sabbagh A, Rodés-Cabau J, Guimaraes L, Kornowski R, Codner P, Okuno T, Pilgrim T, Fiorina C, Colombo A, Mangieri A, Eltchaninoff H, Nombela-Franco L, Van Wiechen MPH, Van Mieghem NM, Tchétché D, Schoels WH, Kullmer M, Tamburino C, Sinning JM, Al-Kassou B, Perlman GY, Danenberg H, Ielasi A, Fraccaro C, Tarantini G, De Marco F, Witberg G, Redwood SR, Lisko JC, Babaliaros VC, Laine M, Nerla R, Castriota F, Finkelstein A, Loewenstein I, Eitan A, Jaffe R, Ruile P, Neumann FJ, Piazza N, Alosaimi H, Sievert H, Sievert K, Russo M, Andreas M, Bunc M, Latib A, Govdfrey R, Hildick-Smith D, Sathananthan J, Hensey M, Alkhodair A, Blanke P, Leipsic J, Wood DA, Nazif TM, Kodali S, Leon MB, Barbanti M |
Journal of the American College of Cardiology. pii: S0735-1097(20)34458-2. doi: 10.1016/j.jacc.2020.02.051 |
PMID: 32327098 |
Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2. |
Rugo HS, Pritchard KI, Gnant M, Noguchi S, Piccart M, Hortobagyi G, Baselga J, Perez A, Geberth M, Csoszi T, Chouinard E, Srimuninnimit V, Puttawibul P, Eakle J, Feng W, Bauly H, El-Hashimy M, Taran T, Burris HA |
Annals of oncology : official journal of the European Society for Medical Oncology. 2014 Mar 10. pii: S0923-7534(19)36498-1. doi: 10.1093/annonc/mdu009. pmc: PMC3969554 |
PMID: 24615500 |
37 Einträge | 1, 2 › » |
Seite 1 / 2
![]() |